Xylo Technologies Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Liron Carmel

İcra Kurulu Başkanı

US$451.0k

Toplam tazminat

CEO maaş yüzdesi	37.5%
CEO görev süresi	5.6yrs
CEO sahipliği	0.005%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	6.2yrs

Son yönetim güncellemeleri

Recent updates

We Believe Medigus' (NASDAQ:MDGS) Earnings Are A Poor Guide For Its Profitability

Sep 28

Medigus jumps 4% as subsidiary Charging Robotics assigns first distributor for its wireless EV robotic charging pad

Jun 17

Medigus launches ADS offering

Jan 11

Medigus expands EV operations with acquisition of autonomous technology, shares up 31%

Jan 08

New finance cheif at Medigus

Dec 01

Medigus shares +42% on plans to enter micro-mobility EV market

Nov 19

Medigus under pressure after increasing stake to ~33% in Polyrizon

Nov 09

CEO Tazminat Analizi

Liron Carmel'un ücretlendirmesi Xylo Technologies'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	-US$16m
Mar 31 2024	n/a	n/a	-US$16m
Dec 31 2023	US$451k	US$169k	-US$16m
Sep 30 2023	n/a	n/a	-US$15m
Jun 30 2023	n/a	n/a	-US$14m
Mar 31 2023	n/a	n/a	-US$12m
Dec 31 2022	US$451k	US$216k	-US$10m
Sep 30 2022	n/a	n/a	-US$8m
Jun 30 2022	n/a	n/a	-US$7m
Mar 31 2022	n/a	n/a	US$107k
Dec 31 2021	US$516k	US$201k	US$7m
Sep 30 2021	n/a	n/a	US$7m
Jun 30 2021	n/a	n/a	US$8m
Mar 31 2021	n/a	n/a	US$2m
Dec 31 2020	US$214k	US$139k	-US$4m
Sep 30 2020	n/a	n/a	-US$10m
Jun 30 2020	n/a	n/a	-US$15m
Mar 31 2020	n/a	n/a	-US$15m
Dec 31 2019	US$202k	US$102k	-US$14m

Tazminat ve Piyasa: Liron 'nin toplam tazminatı ($USD 451.00K ), US pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 652.28K ).

Tazminat ve Kazançlar: Liron 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.

CEO

Liron Carmel (39 yo)

5.6yrs

Görev süresi

US$451,000

Tazminat

Mr. Liron Carmel is an Independent Director at Viewbix Inc. since September 19, 2022. He has been Director at Matomy Media Group Ltd. since May 13, 2020 from July 2020.Mr. Carmel has been Chief Executive...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Smadar Cohen	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Eliyahu Yoresh	Independent Chairman of the Board	6.2yrs	US$404.00k	0.028% $ 614.9
Ronen Rosenbloom	Independent Director	6.2yrs	US$70.00k	0% $ 0
Eli Cohen	Independent Director	6.2yrs	US$76.00k	0% $ 0
Kineret Tzedef	Independent Director	5.4yrs	US$71.00k	0% $ 0
Nancy Agmon-Levin	Member of Scientific Advisory Board	2.7yrs	Veri yok	Veri yok
Avi Schroeder	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Fabio Sonvico	Member of Scientific Advisory Board	no data	Veri yok	Veri yok

6.2yrs

Ortalama Görev Süresi

53yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: XYLO 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.2 yıldır).

Xylo Technologies Yönetim

Yönetim kriter kontrolleri 3/4

Anahtar bilgiler

Son yönetim güncellemeleri

Medigus Ltd., Annual General Meeting, Aug 07, 2023

Medigus Ltd., Annual General Meeting, Jun 16, 2022

High number of new directors

Tatiana Yosef to Step Down as Chief Financial Officer of Medigus Ltd., with Effect from January 15, 2021

Recent updates

First half 2024 earnings released: US$11.33 loss per share (vs US$13.39 loss in 1H 2023)

Full year 2023 earnings released: US$9.50 loss per share (vs US$6.04 loss in FY 2022)

Medigus Ltd.(NasdaqCM:MDGS) dropped from NASDAQ Composite Index

New minor risk - Financial data availability

Medigus Ltd. Announces Launch of Unique Pilot of A Wireless Charging Solution

New minor risk - Share price stability

New minor risk - Shareholder dilution

Medigus Ltd., Annual General Meeting, Aug 07, 2023

existing shareholders and office holders in ScoutCam acquired 46.11% stake in ScoutCam Inc. (OTCPK:SCTC) from Medigus Ltd. (NasdaqCM:MDGS) for $6 million.

M. Arkin (1999) Ltd. acquired 46.11% stake in ScoutCam Inc. (OTCPK:SCTC) from Medigus Ltd. (NasdaqCM:MDGS) for $6 million.

Full year 2022 earnings released: US$6.04 loss per share (vs US$4.42 profit in FY 2021)

Medigus Regains Compliance with Nasdaq Minimum Closing Bid Price Rule

Price target decreased to US$67.50

Medigus says ScoutCam appoints Yehu Ofer as CEO

Consensus forecasts updated

First half 2022 earnings released: US$0.15 loss per share (vs US$0.44 profit in 1H 2021)

Medigus reports 1H results

What Does Medigus Ltd.'s (NASDAQ:MDGS) Share Price Indicate?

Medigus board files a motion to approve an up to $1.6M dividend distribution

Medigus Announces Receipt of Nasdaq Notice of Bid Price Deficiency

Medigus Ltd., Annual General Meeting, Jun 16, 2022

Is Now An Opportune Moment To Examine Medigus Ltd. (NASDAQ:MDGS)?

Full year 2021 earnings released: EPS: US$0.20 (vs US$0.65 loss in FY 2020)

Medigus Ltd. (NasdaqCM:MDGS) acquired a 35.1% stake in Fuel Doctor Holdings, Inc. (OTCPK:FDOC) for $0.26 million.

Medigus Ltd. Micro Mobility Vehicle JV, Revoltz, Launches Pilot Program At A New Autonomous Supermarket

A consortium of investors led by Medigus Ltd. (NasdaqCM:MDGS), L.I.A. Pure Capital Ltd. along with other buyers including a group of individuals completed the acquisition of ParaZero Technologies Ltd from Delta Drone International Limited (ASX:DLT).

Medigus Ltd. Announces First Authorization for Commercial Drone Deliveries in Brazil

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

High number of new directors

We Believe Medigus' (NASDAQ:MDGS) Earnings Are A Poor Guide For Its Profitability

First half 2021 earnings released: EPS US$0.44 (vs US$0.56 loss in 1H 2020)

Medigus Joint Venture, Revoltz Completes First Micromobility Vehicle Functional Prototype

Medigus jumps 4% as subsidiary Charging Robotics assigns first distributor for its wireless EV robotic charging pad

Medigus Ltd. announced delayed 20-F filing

Medigus Forms Joint Venture for the Development of Urban and Logistics Electric Vehicles with Emuze Founders

Medigus Ltd. Initiates Development of Robotic Wireless Charging Pad for Electric Vehicles

New 90-day high: US$3.69

Medigus launches ADS offering

Medigus Ltd. Enters the Wireless Charging Market for Electric Vehicle with New Autonomous Technology

Medigus expands EV operations with acquisition of autonomous technology, shares up 31%

Medigus Ltd. (TASE:MDGS) completed the acquisition of 50.01% stake in Purex Incorporated and Smart Repair Pro, Inc.

New finance cheif at Medigus

Tatiana Yosef to Step Down as Chief Financial Officer of Medigus Ltd., with Effect from January 15, 2021

Medigus Signs MOU to Enter Electric Vehicles and Electric Charging Market

Medigus shares +42% on plans to enter micro-mobility EV market

Medigus under pressure after increasing stake to ~33% in Polyrizon

Medigus Ltd. (TASE:MDGS) signed a share purchase agreement to acquire an unknown stake in Eventer Technologies Ltd.

Medigus Ltd. (TASE:MDGS) agreed to acquire additional 15.1% stake in Gix Internet Ltd (TASE:GIX).

Medigus Ltd. (TASE:MDGS) signed a non-binding letter of intent to acquire a controlling interest of 50.1% in Purex Incorporated and Smart Repair Pro, Inc. for $2.5 million.

Medigus Ltd. (TASE:MDGS) completed the acquisition of Linkury LTD. from Algomizer Ltd (TASE:ALMO).